Our friends at the Union of Concerned Scientists have more details on the food industry’s relentless fight against added sugar labeling.
- “The food industry is proposing two different riders: one that would delay the FDA’s ability to enforce the rule for years, until final guidance on dietary fiber and added sugars is completed, and another that would tie FDA’s enforcement of the new rule to the implementation of USDA’s genetically engineered food disclosure rules, which haven’t yet been written.”
- “This pushback from industry to delay the rule is yet another example of its efforts to thwart science-based rules to keep the status quo, in this case making sure that consumers are kept in the dark about added sugar content for as long as possible.”
- “Another threat to the Nutrition Facts Label revisions is the irksome Gingrich-era bill, the Congressional Review Act. The Congressional Review Act (CRA) allows Congress to render regulations passed within 60 days of the end of the House or Senate sessions null. According to the Congressional Research Service, this could apply to regulations finalized any time after mid-May of this year. Unfortunately, since the FDA published its nutrition facts labeling revision rule on May 27, 2016, it could be on the chopping block.”
- “The final threat is that [President-Elect] Trump’s pick for secretary of the Department of Health and Human Services (HHS) is Tom Price, a physician and Georgia congressman whose voting record reveals his lack of interest in improving the quality of school meals and transparency in the food system.”
- “Without the label changes, it will be extremely difficult for Americans to follow the recommendations of the 2015 Dietary Guidelines for Americans to reduce intake of added sugar to less than 10 percent of daily calories, since there will be no way to know exactly how much added sugar is in a particular food.”
This is precisely why we always recommend that health organization look at current and possible future sponsors’ policy and lobbying history. Any company that actively battles public health policy should not be provided with the privilege of aligning itself with a health organization.